Vardenfil grabs bigger market share

Published: 2007-05-25 06:58:00

Updated: 2007-05-25 06:58:00

Vardenafil preparations, co-marketed by Bayer Korea (trade name: Levitra) and Chong Kun Dang Pharmaceutical (trade name: Yaila), are expanding its share of the domestic anti-impotence drug market.

According to IMS data, the combined market share of two vardenafil preparations took 14.5 percent...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK